Last reviewed · How we verify
NCT03610854
Fitness Trackers During and After Oncological Treatments
NA trial testing Fitness Tracker in Cancer in 50 participants. Status unknown.
31 December 2018
Quick facts
| Lead sponsor | University Hospital Tuebingen |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 50 |
| Start date | 18 April 2018 |
| Primary completion | 31 December 2018 |
| Estimated completion | 31 January 2019 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- Fitness Tracker
Conditions studied
- Cancer — all drugs for Cancer →
- Physical Activity — all drugs for Physical Activity →
- Fatigue — all drugs for Fatigue →
Sponsor
University Hospital Tuebingen
Who can join
18 and older, any sex, with Cancer or Physical Activity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The overall goal of the present trial is to evaluate the patients' compliance for wearing a commercially available fitness tracker during and after oncological treatments.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Acceptance of physical activity monitoring in cancer patients during radiotherapy, the GIROfit phase 2 pilot trial.
Boeke S, Hauth F, Fischer SG, Lautenbacher H, et al · · 2022 · cited 5× · PMID 35402741 · DOI 10.1016/j.tipsro.2022.03.004
Verify or expand the search:
- PubMed search for NCT03610854
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Fitness Tracker
Trials testing the same drug.
- NCT06840028 — Effects of Personalized Exercise Prescriptions Through Mobile Health on Physical Activity and Health Outcomes in the Can · NA · recruiting
- NCT04667182 — A Study of Glucose Control in Participants With Type 1 and Type 2 Diabetes · withdrawn
- NCT03758430 — A Study of Technology to Improve Glucose Control in Participants With Type 1 Diabetes · completed
- NCT03364673 — Stepping Into Survivorship: Harnessing Behavioral Economics to Improve Quality of Life in Ovarian Cancer · NA · completed
- NCT02761018 — Using Technology to Share Fitness Goals and Results to Improve Diabetes Outcomes · NA · completed
Other recruiting trials for Cancer
Currently open trials in the same condition.
- NCT07390045 — Exercise and Cognitive Rehabilitation Interventions for Older Cancer Survivors · NA · recruiting
- NCT07528547 — Hypersight and Ethos In Pediatric Radiotherapy · NA · recruiting
- NCT07481890 — Feasibility and Efficacy of the EMDR Toolbox Method in Cancer Patients. · NA · recruiting
- NCT07402057 — Implementation and Evaluation of a Program Aimed at Facilitating Palliative Care Conversations · NA · recruiting
- NCT07305740 — On-Trac: An Online Intervention for Cancer Survivors Managing Anxiety · NA · recruiting
Other University Hospital Tuebingen trials
Trials by the same sponsor.
- NCT07378670 — DEfeating PEnile CAncer-2 · NA · recruiting
- NCT07276503 — Verification of a New Predictive Delirium Score in Adults With Elective Cardiac Valve or Bypass Surgery With Perioperati · not yet recruiting
- NCT07411365 — Dual-task Cognitive-motor Telerehabilitation in Persons With PD-MCI · NA · not yet recruiting
- NCT06953791 — Comparison of Quality of Life During a Flare of Crohn's Disease Treated With Prednisolone or aCDED With PEN in Adult Pat · Phase 2 · recruiting
- NCT07378891 — Artificial-Intelligence-based Early Detection of Diabetic Retinopathy (FUNDUS AI) · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03610854 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital Tuebingen
- Last refreshed: 1 August 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03610854.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing